Joined PC’UP deep-tech incubator
A51 has been selected for the PC'UP deep-tech incubator and has moved into its new space at Institut Pierre-Gilles de Gennes.
Selected as a Deep Tech Pioneer by Hello Tomorrow
Chosen from 4,800+ applications across 108 countries for our intelligent molecular programming engine, ADA.
Selected for STATION F’s Future 40 · 2025
Top 40 startups of the year at the world’s largest startup campus top 4% of 1,000 companies.
A51 wins the i-Lab 2025 Innovation Award
The national deeptech award rigorous validation of business, science, and ambition, won in the same year A51 launched.
Marina speaks at Bits in Bio, Paris RNA in next-gen therapeutics
Marina Katava and Félix Raimundo, PhD share how A51 is advancing RNA therapeutics for complex diseases at Paris's Bits in Bio gathering of biotech founders, scientists and investors.
A51 presents at the RNA Club, École normale supérieure, Paris
First company ever invited to present at the ENS RNA Club — joining an audience of experts who see RNA as biology’s next inflection point.
Marina & A51 awarded the Female Founders Fellowship
Recognizing Marina Katava and A51 among a select cohort of female-led deeptech companies building at the frontier of biology.
A51 joins the Boost VC BioResidency in San Mateo
Four weeks in Silicon Valley with deep-tech founders, scientists, and investors shaping the future of biotech.
A51 joins Agoranov, France’s leading deeptech incubator
Access to a powerful ecosystem of mentors, investors, and lab infrastructure to accelerate A51’s growth.
Stanford Drug Discovery Symposium 2025
From Ionis CSO Frank Bennett on RNA-based therapies to Jennifer Doudna’s insights, RNA innovation is accelerating, and A51 is building at the frontier.
Out of stealth at Entrepreneurs First Demo Day, San Francisco
A51 launched publicly at EF Demo Day in SF, alongside some of the most exciting early-stage companies and in our signature yellow jumpers.